Hybio Pharmaceutical Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 2.9yrs |
Recent management updates
Recent updates
Investor Optimism Abounds Hybio Pharmaceutical Co., Ltd. (SZSE:300199) But Growth Is Lacking
Sep 30
Here's Why Hybio Pharmaceutical (SZSE:300199) Can Afford Some Debt
Jul 20Hybio Pharmaceutical Co., Ltd.'s (SZSE:300199) Price Is Out Of Tune With Revenues
Jun 03Hybio Pharmaceutical Co., Ltd.'s (SZSE:300199) 27% Share Price Surge Not Quite Adding Up
Feb 29Is Hybio Pharmaceutical (SZSE:300199) Using Too Much Debt?
Feb 26CEO
Hybio Pharmaceutical has no CEO, or we have no data on them.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive VP & Director | 4.8yrs | CN¥2.10m | 0.060% CN¥ 6.3m | |
| VP, Secretary & Director | 2.9yrs | CN¥803.20k | no data | |
| Independent Director | no data | CN¥110.00k | no data | |
| Non-Independent Director | 4.8yrs | CN¥60.00k | 2.46% CN¥ 259.5m | |
| Member of Non-Employee Supervisory Board | 2.9yrs | no data | no data | |
| Chairman of Supervisory Board | 2.9yrs | no data | no data | |
| Independent Director | 2.9yrs | CN¥120.00k | no data | |
| VP & Director | 3.8yrs | CN¥755.90k | no data | |
| Independent Director | 2.9yrs | CN¥120.00k | no data | |
| Vice Chairman | 2.9yrs | CN¥60.00k | 8.15% CN¥ 860.2m | |
| Chairman | 2.9yrs | CN¥1.12m | 12.41% CN¥ 1.3b | |
| Supervisor | no data | no data | no data |
2.9yrs
Average Tenure
47.5yo
Average Age
Experienced Board: 300199's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.